Strategic Partnerships Recent collaborations with Aycan DigitalSystems and Golden State Dermatology indicate a growing openness among radiology informatics providers and large dermatology practices to pilot and adopt virtual biopsy technology. This suggests Q1–Q2 2025 may present opportunity to target similar radiology and dermatology networks for joint trials, pilot programs, and expanded trials.

Clinical Grant Interest NCI grant funding highlighting support for deep learning developments in predicting progression of actinic keratosis to squamous cell carcinoma signals strong interest in AI-enabled diagnostics. Leverage this by presenting AI-driven analytics licenses and co-development opportunities to oncology-focused clinics and university cancer centers.

Pilot Feasibility Momentum Launch of a pilot feasibility study in 2022 demonstrates a track record of early-stage validation. This creates a narrative to approach mid-sized dermatology groups and imaging centers with phased deployment plans, ROI projections, and metrics from prior pilots to reduce sales risk.

Clinical NetworkAccess Partnerships with multi-location practices like Golden State Dermatology imply access to a broad clinical network. Use this to propose multi-site deployments, data-sharing agreements, and centralized support packages to accelerate adoption across affiliated clinics.

Funding Ready Story A combined funding profile showing under $1M revenue yet $12M total funding positions Enspectra as a high-potential growth story for early adopters, healthtech VCs, and hospital innovation programs. Frame conversations around strategic value, path to scale, and downstream revenue opportunities with prospective investors and healthcare systems.